These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 2139097

  • 21. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
    Carayanniotis G, Halloran PF.
    Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
    [Abstract] [Full Text] [Related]

  • 22. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N, Fontaine P, Perreault C.
    Transplantation; 1994 Jul 15; 58(1):59-67. PubMed ID: 8036709
    [Abstract] [Full Text] [Related]

  • 23. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M, Kaplan AM.
    J Immunol; 1985 Aug 15; 135(2):1510-7. PubMed ID: 3159794
    [Abstract] [Full Text] [Related]

  • 24. Expression of H-2b alloantigens in a variant of a Moloney virus-induced YAC (H-2a) lymphoma.
    Kedar E, Schwartzbach M, Klein E.
    Eur J Cancer Clin Oncol; 1982 Sep 15; 18(9):861-5. PubMed ID: 6185344
    [Abstract] [Full Text] [Related]

  • 25. Selection of the T cell repertoire during ontogeny: limiting dilution analysis.
    Teh HS, Bennink J, Von Boehmer H.
    Eur J Immunol; 1982 Oct 15; 12(10):887-92. PubMed ID: 6983444
    [Abstract] [Full Text] [Related]

  • 26. Regulatory mechanisms in cytotoxic T lymphocyte development. II. Dissociation of in vitro cytotoxic T-lymphocyte and suppressor T-cell activities with L-ornithine.
    Susskind BM, Schall R, Dixon ED.
    Cell Immunol; 1986 Sep 15; 101(2):512-23. PubMed ID: 2944613
    [Abstract] [Full Text] [Related]

  • 27. A method for analysing the clonal precursors of concanavalin A-induced suppressor cells.
    Good MF, Halliday JW, Powell LW.
    J Immunol Methods; 1985 Jun 25; 80(2):163-75. PubMed ID: 2861237
    [Abstract] [Full Text] [Related]

  • 28. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH, Miller RG.
    J Immunol; 1985 Feb 25; 134(2):684-90. PubMed ID: 2578160
    [Abstract] [Full Text] [Related]

  • 29. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S.
    Eur J Immunol; 1991 Sep 25; 21(9):2095-103. PubMed ID: 1679712
    [Abstract] [Full Text] [Related]

  • 30. Antigen competition in cytotoxic T cell response to minor histocompatibility antigens.
    Lai PK.
    Transplantation; 1985 Jun 25; 39(6):638-43. PubMed ID: 3873732
    [Abstract] [Full Text] [Related]

  • 31. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS, Sharrow SO, Shearer GM.
    J Immunol; 1987 Sep 15; 139(6):1840-9. PubMed ID: 2957440
    [Abstract] [Full Text] [Related]

  • 32. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF, Nossal GJ.
    J Immunol; 1983 Dec 15; 131(6):2662-9. PubMed ID: 6227660
    [Abstract] [Full Text] [Related]

  • 33. Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response.
    Fitch FW, Engers HD, Cerottini JC, Bruner KT.
    J Immunol; 1976 Mar 15; 116(3):716-23. PubMed ID: 56399
    [Abstract] [Full Text] [Related]

  • 34. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S, Azuma T, Shimizu J, Shima J, Kitagawa S, Hamaoka T, Fujiwara H.
    J Immunol; 1988 Aug 01; 141(3):721-7. PubMed ID: 2456330
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A glycopeptide extract can inhibit cytotoxic T lymphocyte-target cell conjugation in an H-2-restricted manner.
    Pimlott NJ, Miller RG.
    J Immunol; 1984 Oct 01; 133(4):1763-8. PubMed ID: 6236257
    [Abstract] [Full Text] [Related]

  • 37. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F, Collavo D, Zanovello P, Cerundolo V, Biasi G.
    Immunology; 1985 Feb 01; 54(2):265-74. PubMed ID: 2578429
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Generation of specific antitumor cytotoxic T-lymphocytes in monoculture can be inhibited by T-suppressors from tumor-bearing mice.
    Lupatov AYu, Brondz BD.
    Cancer Biother; 1994 Feb 01; 9(2):123-9. PubMed ID: 7812361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.